Evidence Level:Sensitive: D – Preclinical
Title:
Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action
Excerpt:Overexpression of CSMD1 sensitized AI-resistant cells to anastrozole but not to the other two AIs.
DOI:10.1172/jci.insight.137571